| Gurjeet S Grover, MD | |
|
5957 Fashion Point Dr, South Ogden, UT 84403-5180 | |
| (385) 492-4930 | |
| Not Available |
| Full Name | Gurjeet S Grover |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 22 Years |
| Location | 5957 Fashion Point Dr, South Ogden, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972721801 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 8197943 (Utah) | Secondary |
| 207RC0200X | Internal Medicine - Critical Care Medicine | 8197943-1205 (Utah) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Portneuf Medical Center | Pocatello, ID | Hospital |
| Ogden Regional Medical Center | Ogden, UT | Hospital |
| Mckay Dee Hospital | Ogden, UT | Hospital |
| Eastern Idaho Regional Medical Center | Idaho falls, ID | Hospital |
| Davis Hospital And Medical Center | Layton, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ogden Pulmonary Associates Pllc | 3678638517 | 8 |
| Ogden Pulmonary Associates Pllc | 3678638517 | 8 |
| Idaho Falls Community Hospital Llc | 9032441597 | 9 |
News Archive
Jessica Zègre-Hemsey, a cardiac monitoring expert at the University of North Carolina at Chapel Hill, and her colleagues at the University of California San Francisco, revealed more than 2.5 million alarms were triggered on bedside monitors in a single month - the first figure ever reported from a real-world hospital setting.
The altered metabolism of two essential amino acids helps drive the development of the most common and lethal form of brain cancer, according to a new study led by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
Micromet, Inc., a biopharmaceutical company focused on the development and commercialization of next-generation antibodies for the treatment of cancer, today announced that data on its lead product candidate blinatumomab will be reported at two upcoming medical meetings.
MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) and Proteros Biostructures announced today that they have been awarded a grant by the German Federal Ministry of Education and Research, BMBF. The funding of approximately EUR 850,000 supports both companies in establishing a new technology platform for efficient structural characterization of antibody-antigen-complexes.
› Verified 5 days ago
| Entity Name | Ihc Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629260880 PECOS PAC ID: 1850209420 Enrollment ID: O20031105000079 |
News Archive
Jessica Zègre-Hemsey, a cardiac monitoring expert at the University of North Carolina at Chapel Hill, and her colleagues at the University of California San Francisco, revealed more than 2.5 million alarms were triggered on bedside monitors in a single month - the first figure ever reported from a real-world hospital setting.
The altered metabolism of two essential amino acids helps drive the development of the most common and lethal form of brain cancer, according to a new study led by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
Micromet, Inc., a biopharmaceutical company focused on the development and commercialization of next-generation antibodies for the treatment of cancer, today announced that data on its lead product candidate blinatumomab will be reported at two upcoming medical meetings.
MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) and Proteros Biostructures announced today that they have been awarded a grant by the German Federal Ministry of Education and Research, BMBF. The funding of approximately EUR 850,000 supports both companies in establishing a new technology platform for efficient structural characterization of antibody-antigen-complexes.
› Verified 5 days ago
| Entity Name | Ogden Pulmonary Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457596801 PECOS PAC ID: 3678638517 Enrollment ID: O20090210000370 |
News Archive
Jessica Zègre-Hemsey, a cardiac monitoring expert at the University of North Carolina at Chapel Hill, and her colleagues at the University of California San Francisco, revealed more than 2.5 million alarms were triggered on bedside monitors in a single month - the first figure ever reported from a real-world hospital setting.
The altered metabolism of two essential amino acids helps drive the development of the most common and lethal form of brain cancer, according to a new study led by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
Micromet, Inc., a biopharmaceutical company focused on the development and commercialization of next-generation antibodies for the treatment of cancer, today announced that data on its lead product candidate blinatumomab will be reported at two upcoming medical meetings.
MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) and Proteros Biostructures announced today that they have been awarded a grant by the German Federal Ministry of Education and Research, BMBF. The funding of approximately EUR 850,000 supports both companies in establishing a new technology platform for efficient structural characterization of antibody-antigen-complexes.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gurjeet S Grover, MD Po Box 150627, Ogden, UT 84415-0627 Ph: (385) 492-4930 | Gurjeet S Grover, MD 5957 Fashion Point Dr, South Ogden, UT 84403-5180 Ph: (385) 492-4930 |
News Archive
Jessica Zègre-Hemsey, a cardiac monitoring expert at the University of North Carolina at Chapel Hill, and her colleagues at the University of California San Francisco, revealed more than 2.5 million alarms were triggered on bedside monitors in a single month - the first figure ever reported from a real-world hospital setting.
The altered metabolism of two essential amino acids helps drive the development of the most common and lethal form of brain cancer, according to a new study led by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
Micromet, Inc., a biopharmaceutical company focused on the development and commercialization of next-generation antibodies for the treatment of cancer, today announced that data on its lead product candidate blinatumomab will be reported at two upcoming medical meetings.
MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) and Proteros Biostructures announced today that they have been awarded a grant by the German Federal Ministry of Education and Research, BMBF. The funding of approximately EUR 850,000 supports both companies in establishing a new technology platform for efficient structural characterization of antibody-antigen-complexes.
› Verified 5 days ago
Wojciech C Janowski, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 5957 Fashion Point Dr Ste 103, South Ogden, UT 84403 Phone: 385-492-4930 Fax: 385-492-4449 | |
Dr. Charles Thomas Ivester, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 5957 Fashion Point Dr Ste 103, South Ogden, UT 84403 Phone: 385-492-4930 Fax: 385-492-4449 | |
Robert Cheney, DO Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 5957 Fashion Point Dr Ste 103, South Ogden, UT 84403 Phone: 385-492-4930 Fax: 801-807-7597 | |
Christopher K Anderson, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 5957 Fashion Point Dr Ste 103, South Ogden, UT 84403 Phone: 385-492-4930 Fax: 385-492-4449 | |
Mohammad Omer Syed, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 5957 Fashion Point Dr Ste 103, South Ogden, UT 84403 Phone: 385-492-4930 Fax: 385-492-4449 | |
Dr. Gaurav Dagar, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 5957 Fashion Point Dr, South Ogden, UT 84403 Phone: 385-492-4930 Fax: 385-492-4449 | |
Terrence Wayne Andrews, DO Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 5957 Fashion Point Dr Ste 103, South Ogden, UT 84403 Phone: 385-492-4930 Fax: 385-492-4449 |